Review Article
Vaccines against Human Carcinomas: Strategies to Improve Antitumor Immune Responses
Table 1
Vaccine-delivery systems.
| Vaccine-delivery systems | Immunization against multiple antigens* | Immunization against specified antigen(s) |
| Cell-based | Cell-based | Autologous whole-tumor cells | DCs pulsed with peptide | Allogeneic whole-tumor cells | Genetically-modified DCs | Genetically-modified tumor cells | | DCs-tumor fusion | Protein/Peptide based | DCs loaded with tumor lysate | Protein Peptide Agonist peptide Antiidiotype MAb Mab fusion proteins | DCs transfected with tumor-derived RNA | | Protein/Peptide based | | Tumor lysates | Vector-based | Heat shock proteins-tumor peptides | Plasmid DNA | | | | Bacterial vectors | | Listeria | | Salmonella | | Yeast vectors | | Viral vectors | | Adenovirus | | Vaccinia | | Avipox (fowlpox) | | MVA |
|
|
formulation includes known and unknown antigens.
|